Patrick Ryan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Patrick Ryan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Adjoa Obo-Akwa
Univ Ghana, Med Sch, Dept Med & Therapeut, Accra, Ghana
1 shared publication- Awewura Kwara
Department of Medicine, University of Florida College of Medicine, Gainesville, FL
1 shared publication Azizullah Beran
1 shared publicationDaryl Ramai
1 shared publicationElizabeth Odegard
Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH USA
1 shared publicationEugene Nwankwo
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (10)
Atypical Hemolytic Uremic Syndrome in a Patient With Inflammatory Bowel Disease
Atypical hemolytic uremic syndrome is a life-threatening thrombotic microangiopathy due to complement dysregulation that can be triggered by systemic inflammatory states. We describe a patient with inflammatory bowel disease presenting with pain, melena, and laboratory test results showing hemolytic anemia, thrombocytopenia, and acute kidney injury. Subsequent testing led to a diagnosis of atypical hemolytic uremic syndrome, prompting initiation of eculizumab with rapid improvement in his hemolysis, thrombocytopenia, and acute kidney injury. Providers should maintain a high index of suspicion for uncommon but grave conditions associated with inflammatory bowel disease and consider complement testing if thrombotic microangiopathy is suspected.
- 25 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (10)
Open AccessAtypical Hemolytic Uremic Syndrome in a Patient With Inflammatory Bowel Disease
Atypical hemolytic uremic syndrome is a life-threatening thrombotic microangiopathy due to complement dysregulation that can be triggered by systemic inflammatory states. We describe a patient with inflammatory bowel disease presenting with pain, melena, and laboratory test results showing hemolytic anemia, thrombocytopenia, and acute kidney injury. Subsequent testing led to a diagnosis of atypical hemolytic uremic syndrome, prompting initiation of eculizumab with rapid improvement in his hemolysis, thrombocytopenia, and acute kidney injury. Providers should maintain a high index of suspicion for uncommon but grave conditions associated with inflammatory bowel disease and consider complement testing if thrombotic microangiopathy is suspected.
- 25 August 2026
- Published by Elsevier in Pancreatology
- Vol. 26 (7) , 972-981
Peripheral and splanchnic venous thromboembolism in acute and infected necrotizing pancreatitis: A systematic review and meta-analysis
- 25 August 2026
- Published by Elsevier in Pancreatology
- Vol. 26 (7) , 972-981
Peripheral and splanchnic venous thromboembolism in acute and infected necrotizing pancreatitis: A systematic review and meta-analysis
- Open Access
- 2 October 2024
- Published by Elsevier in Journal of Clinical Virology
- Vol. 175, 105733
Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection
- 2 October 2024
- Published by Elsevier in Journal of Clinical Virology
- Vol. 175, 105733
Open AccessHepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection